Clinical utility of ramucirumab in non-small-cell lung cancer

Overview of attention for article published in Biologics: Targets & Therapy, July 2019

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age

Mentioned by

twitter: 2 tweeters
facebook: 2 Facebook pages

reddit: 1 Redditor

Citations

dimensions_citation: 7 Dimensions

Readers on

mendeley: 29 Mendeley

Summary Twitter Facebook Reddit Dimensions citations

So far, Dimensions has found 7 publications that cite this research output.

7

The most recent citing publications are shown below. View all 7 publications that cite this research output on Dimensions.

A real-world study of Afatinib plus ramucirumab in treatment-naïve, EGFR-mutated, non–small cell lung cancer

Article in BMC Cancer (May 2023)

Biochanin A inhibits lung adenocarcinoma progression by targeting ZEB1

Article in Discover Oncology (December 2022)

Emerging Trends in Immunotherapy for Cancer

Article in Diseases (September 2022)